Dr. Richard Silver, professor of Medicine and Director of the Leukemia and Myeloproliferative Center at New York Presbyterian-Weill Cornell Medical Center, needs no introduction to readers of MPNforum Magazine. The senior member of MPNclinic, he has been the subject of many articles and has contributed his own comments (and dissent) from time to time.
His career extends from the dark ages of hematology to the most advanced clinical trials now in progress. Along the way he has published more than 250 articles, led investigation into landmark MPN therapies. For most of us, however, he is known as a compassionate doctor, voted among New York City’s best. Internationally, he’s the unquestioned, deeply grounded authority on Interferon use in MPN patients.
At ASH, in a free-ranging discussion, he expressed his views on Interferon and announced the opening of a randomized clinical trial for very early stage MF patients designed to test low dose interferon against observation-only on a 2:1 basis with the option to crossover in case of progression.
Those interested in learning more about participating should contact his assistant, Maria Wright: <firstname.lastname@example.org>
(NOTE: Because of a shift to HTML5 and Flash Player requirements the embedded video may not play on some browers. Please click on the links below which will take you to the video uploaded to YouTube. Thanks.)
© Zhenya Senyak and MPNforum.com, 2012. Unauthorized use and/or duplication of this material without express and written permission from this blog’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Zhenya Senyak and MPNforum.com with appropriate and specific direction to the original content.